Georgiy Yegiazarov, PA

Georgiy Yegiazarov practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Georgiy Yegiazarov's NPI, 1346724770, was assigned on September 21, 2018. Georgiy Yegiazarov graduated from Pennsylvania State University College of Medicine in 2018. Georgiy Yegiazarov holds New York license 022633.

Georgiy Yegiazarov's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Georgiy Yegiazarov's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Georgiy Yegiazarov is also affiliated with Wynn Hospital. The medical group on file is Department of Medicine. Dmand AI also links Georgiy Yegiazarov to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Georgiy Yegiazarov practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Georgiy Yegiazarov's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Georgiy Yegiazarov is licensed in New York.

CMS data shows 400 Medicare services from Georgiy Yegiazarov across 4 procedure codes in 2024, for 131 Medicare patients. Medicare paid $17,802 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Georgiy Yegiazarov in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have diabetes, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Georgiy Yegiazarov's median patient age at 61, with 39% women.

In 2024, Georgiy Yegiazarov wrote 3,540 Medicare Part D claims for 601 patients. 31% of them were for generic drugs. CMS names the drug for 3,176 of them, across 56 drugs with 11 or more claims each, at $1,894,390 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Georgiy Yegiazarov for performance year 2024, reported as part of a group. Georgiy Yegiazarov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Georgiy Yegiazarov as offering telehealth.

Georgiy Yegiazarov graduated from Pennsylvania State University College of Medicine in 2018.